Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cerecin logo — Cerecin is a healthcare company with more than 20 years of i...

Cerecin

Cerecin is a healthcare company with more than 20 years of innovation and leadership in brain health.

Founded 2001 Singapore Singapore 37 employees Series B Total: $35.04B Biotechnology, Health Care +2

General Information

Company Name Cerecin
Founded Year 2001
Location Singapore Singapore
Employees 37
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Cerecin. To contact Cerecin, visit cerecin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cerecin compare?

A PDF of Cerecin and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cerecin soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cerecin

Cerecin is a global healthcare company founded in 2001 and headquartered in Singapore. The company, with its slogan "Cerecin is a healthcare company with almost 20 years of innovation and leadership in brain health," has almost two decades of experience in the biotechnology and healthcare industries. Cerecin's innovative approach focuses on developing evidence-based solutions including pharmaceuticals, medical foods, diagnostics, medical devices, and e-health products tailored to address a wide range of brain health issues, from memory impairment to severe neurological diseases. In the latest funding round, Series B investment at 28 September 2022, Cerecin secured investments from SK Securities and K&T partners. This demonstrates the confidence of prominent investors in the company's vision and potential. With its strong track record and expertise, Cerecin is poised to make significant strides in the global healthcare and biotechnology sectors.

Taxonomy: Brain Health, Alzheimer's, Drug Development, Clinical Research, Medical Foods, Diagnostics, E-Health Products, Neurological Diseases, Memory Impairment, Innovation, Therapeutics, Denver, Colorado

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 2
SK Securities, K&T partners
28 Sep 2022
Series B $7.22M -
16 Aug 2022
Series A KRW35.00B 10
Partners Investment IBK Capital KB Financial Group
Partners Investment, IBK Capital +8
18 Oct 2021
Series A $10.00M -
01 Feb 2021
Venture Round $17.64M -
26 Mar 2018
Venture Round €9.49M -
15 Mar 2010

Cerecin Alternatives & Competitors

View All Alternatives
Cerecin vs
Accera
Accera

Pioneering breakthroughs in neurodegenerative therapies for Alzheimer’s, Parkinson’s, and age-relate...

Venture round
11-50 employees
Biotechnology, Health Care
Cerecin vs
Neurotrope Inc.
Neurotrope Inc. United States

Developing a new approach to combating Alzheimer's disease and other neurodegenerative diseases.

Series A
3 employees
Biotechnology, Health Care
Cerecin vs
ProteoTech
ProteoTech

Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996

Venture round
2-10 employees
Biotechnology, Health Care
View all alternatives

FAQ About Cerecin

Cerecin is a healthcare company with more than 20 years of innovation and leadership in brain health.
Cerecin was founded in 2001.
Cerecin is headquartered in Singapore.
Cerecin operates in Biotechnology, Health Care, Health and Wellness and Life Sciences. Its work centres on Brain Health, Alzheimer's, Drug Development and Clinical Research.
Cerecin has approximately 37 employees.
Cerecin has completed 6 funding rounds, raising a total of $35.04B. The latest funding stage is Series B.
Top alternatives and competitors to Cerecin include Accera, Neurotrope Inc., ProteoTech, Cognoptix, Ascendant Biotech Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cerecin and Accera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cerecin, https://bouncewatch.com/company/cerecin, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes